This is the story of a nurse in Michigan who decided to become the person she always knew she could be after experiencing the ...

The next issue of Sunrise will soon be in your inbox. We encountered an issue signing you up. Please try again Interested in ...

The WHO has issued its first comprehensive guidelines for managing Ebola and Marburg diseases, stressing early supportive ...

Design Therapeutics has its proprietary GeneTAC platform, which gives them a small-molecule way to target repeat-expansion ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

As you all know, Alnylam is pioneering an entirely new class of medicines to treat human disease. This generational technology leverages the mechanism of RNA interference, a natural process of gene ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World Health Organization (WHO) has released its first comprehensive guidelines for ...

As the Democratic Republic of the Congo is battling an Ebola disease outbreak caused by the Bundibugyo virus, the World ...

Bad trades, poor coaching and terrible communication all conspired to undercut a championship environment. There was plenty of blame on all sides.

A local doctor is building a medical facility he hopes will relieve a life-threatening bed shortage at King Edward VII ...

There are currently no approved drugs that target Bundibugyo - the species of Ebola responsible for this outbreak.

Manikomycin is being hailed as a potential breakthrough in the fight against antibiotic-resistant bacteria. Perhaps it is.